Fortress Biotech
FBIO
60 hedge funds and large institutions have $30.6M invested in Fortress Biotech in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 32 closing their positions.
404% more call options, than puts
Call options by funds: $6.18M | Put options by funds: $1.23M
136% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 11
26% less funds holding
Funds holding: 81 → 60 (-21)
59% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 32
81% less capital invested
Capital invested by funds: $158M → $30.6M (-$128M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.25M |
| 2 |
RA
Royce & Associates
New York
|
+$1.36M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$856K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$812K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$804K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.3M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$13.5M |
| 3 |
Jennison Associates
New York
|
-$11.5M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$9.79M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.3M |
FBIO Hedge Fund Activity: Q4 2013 in Review
60 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2013, worth a combined $30.6M — down 81% from $158M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of FBIO and 13 opened new positions — a net loss of 19 holders — while 11 trimmed existing stakes and 26 added.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $2.25M. The largest seller was Fidelity Investments, exiting entirely with an estimated $35.3M sold.
- 60 institutional investors held Fortress Biotech (FBIO) as of Q4 2013, down from 81 in Q3 2013.
- Funds reported $30.6M of Fortress Biotech stock for Q4 2013, down 81% quarter-over-quarter.
- 13 funds opened new Fortress Biotech positions in Q4 2013 and 32 closed out, a net change of -19 holders.
- The largest Fortress Biotech buyer in Q4 2013 was Nantahala Capital Management, an estimated $2.25M added.
- The largest Fortress Biotech seller in Q4 2013 was Fidelity Investments, an estimated $35.3M sold.
Based on aggregated 13F filings for Q4 2013.